Insmed, Inc. (NASDAQ:INSM – Get Free Report) has been assigned a consensus rating of “Buy” from the seventeen ratings firms that are currently covering the firm, MarketBeat Ratings reports. Seventeen equities research analysts have rated the stock with a buy …